Tonix Pharmaceuticals Holding Corp (TNXP)
0.16
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
0.16
0.00 (0.00%)
After-Hours: 20:00
Tonix Pharmaceuticals Cash from Operations (TTM): -102.00M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -102.00M |
September 30, 2023 | -101.96M |
June 30, 2023 | -102.11M |
March 31, 2023 | -99.92M |
December 31, 2022 | -98.05M |
September 30, 2022 | -98.20M |
June 30, 2022 | -87.61M |
March 31, 2022 | -85.54M |
December 31, 2021 | -75.56M |
September 30, 2021 | -67.03M |
June 30, 2021 | -69.36M |
March 31, 2021 | -60.30M |
December 31, 2020 | -48.57M |
September 30, 2020 | -41.34M |
June 30, 2020 | -32.70M |
March 31, 2020 | -27.37M |
December 31, 2019 | -26.68M |
September 30, 2019 | -26.82M |
June 30, 2019 | -25.07M |
March 31, 2019 | -25.84M |
December 31, 2018 | -23.97M |
September 30, 2018 | -22.07M |
June 30, 2018 | -22.23M |
March 31, 2018 | -21.10M |
December 31, 2017 | -19.13M |
Date | Value |
---|---|
September 30, 2017 | -19.64M |
June 30, 2017 | -22.99M |
March 31, 2017 | -26.62M |
December 31, 2016 | -37.31M |
September 30, 2016 | -43.78M |
June 30, 2016 | -47.72M |
March 31, 2016 | -48.96M |
December 31, 2015 | -42.53M |
September 30, 2015 | -38.83M |
June 30, 2015 | -31.37M |
March 31, 2015 | -27.83M |
December 31, 2014 | -22.84M |
September 30, 2014 | -18.15M |
June 30, 2014 | -16.16M |
March 31, 2014 | -11.22M |
December 31, 2013 | -8.517M |
September 30, 2013 | -6.491M |
June 30, 2013 | -4.929M |
March 31, 2013 | -5.297M |
December 31, 2012 | -5.713M |
September 30, 2012 | -5.674M |
June 30, 2012 | -4.933M |
March 31, 2012 | -4.034M |
December 31, 2011 | -2.638M |
September 30, 2011 | -2.394M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-102.11M
Minimum
Jun 2023
-25.07M
Maximum
Jun 2019
-67.17M
Average
-69.36M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
ACADIA Pharmaceuticals Inc | 16.70M |
PetVivo Holdings Inc | -7.190M |
Acurx Pharmaceuticals Inc | -9.801M |
Kezar Life Sciences Inc | -81.64M |
Allakos Inc | -116.48M |